|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | |
| G01N 33/68 | |||
| A61K 39/00 |
| (11) | Number of the document | 3011345 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14752744.4 |
| Date of filing the European patent application | 2014-08-06 | |
| (97) | Date of publication of the European application | 2016-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/049957 |
| Date | 2014-08-06 |
| (87) | Number | WO 2015/021166 |
| Date | 2015-02-12 |
| (30) | Number | Date | Country code |
| 201361863299 P | 2013-08-07 | US | |
| 201361913180 P | 2013-12-06 | US |
| (72) |
MCKNIGHT, Susan Faas, US
COFIELL, Roxanne, US
KUKREJA, Anjli, US
BEDARD, Krystin, A., US
YAN, Yan, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
100 College St., New Haven, Connecticut 06510,
US
|
| (54) | ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS |
| ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS |